tiprankstipranks
Advertisement
Advertisement

Fulgent Genetics raises FY24 EPS view to 33c from (30c), consensus (39c)

Backs FY24 revenue view $280M, consensus $282.17M. Paul Kim, CFO, said, “We are pleased with our financial performance in the third quarter and our trajectory for the remainder of 2024, as we continue to grow core revenue and improve operations.”

Claim 30% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1